[
  {
    "ts": null,
    "headline": "Why Organon Is A Top Pick For Income Investors",
    "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
    "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742252303,
      "headline": "Why Organon Is A Top Pick For Income Investors",
      "id": 133211092,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472143072/image_1472143072.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
      "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=7eb45cacc93b9bd6acdb1f5797ab05484657d4f6fcdddeeb14c3e79f0d4cabd1",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742229060,
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "id": 133213313,
      "image": "",
      "related": "LLY",
      "source": "MarketWatch",
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=7eb45cacc93b9bd6acdb1f5797ab05484657d4f6fcdddeeb14c3e79f0d4cabd1"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: A Safe Harbor Amid Market Volatility",
    "summary": "Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here to read why LLY is a Strong Buy.",
    "url": "https://finnhub.io/api/news?id=4215e8f31df31fc520097fb916458201b06cc66a4fe4fcc11ce71808cd59370a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742223484,
      "headline": "Eli Lilly: A Safe Harbor Amid Market Volatility",
      "id": 133209130,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2175801702/image_2175801702.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here to read why LLY is a Strong Buy.",
      "url": "https://finnhub.io/api/news?id=4215e8f31df31fc520097fb916458201b06cc66a4fe4fcc11ce71808cd59370a"
    }
  }
]